EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Therapeutic Potential of Exosomes vs. Matrix-Bound Nanovesicles from Human Umbilical Cord Mesenchymal Stromal Cells in Osteoarthritis Treatment

Timofey O Klyucherev iD, Maria A Peshkova iD, Daria P Revokatova iD, Natalia B Serejnikova iD, Nafisa M Fayzullina, Alexey L Fayzullin iD, Boris P Ershov, Yana I Khristidis, Irina I Vlasova, Nastasia V Kosheleva, Andrey A Svistunov, Peter S Timashev

International Journal of Molecular Sciences · 28.10.2024 · 25 (21) · 11564

DOI: 10.3390/ijms252111564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.10.2024. Verfasst von Timofey O Klyucherev und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Regenerative Medicine, I. M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Exosomes, Umbilical Cord, Osteoarthritis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Science and Higher Education of the Russian Federation, Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a degenerative joint disease with limited therapeutic options, where inflammation plays a critical role in disease progression. Extracellular vesicles (EV) derived from mesenchymal stromal cells (MSC) have shown potential as a therapeutic approach for OA by modulating inflammation and alleviating degenerative processes in the joint. This study evaluated the therapeutic effects for the treatment of OA of two types of EV—exosomes and matrix-bound nanovesicles (MBV)—both derived from the human umbilical cord MSC (UC-MSC) via differential ultracentrifugation. Different phenotypes of human monocyte-derived macrophages (MDM) were used to study the anti-inflammatory properties of EV in vitro, and the medial meniscectomy-induced rat model of knee osteoarthritis (MMx) was used in vivo. The study found that both EV reduced pro-inflammatory cytokines IL-6 and TNF-α in MDM. However, exosomes showed superior results, preserving the extracellular matrix (ECM) of hyaline cartilage, and reducing synovitis more effectively than MBVs. Additionally, exosomes downregulated inflammatory markers (TNF-α, iNOS) and increased Arg-1 expression in macrophages and synovial fibroblasts, indicating a stronger anti-inflammatory effect. These results suggest UC-MSC exosomes as a promising therapeutic option for OA, with the potential for modulating inflammation and promoting joint tissue regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsExosomesUmbilical CordOsteoarthritisHumansAnimalsRatsExtracellular VesiclesExtracellular MatrixMacrophagesMaleDisease Models, Animal

Stichwörter der Autor:innen

exosomesmatrix-bound nanovesiclesmesenchymal stromal cellsmonocyte-derived macrophagesosteoarthritis

Autor:innen und Institutionen

  • Institute for Regenerative Medicine, I. M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
  • Laboratory of Clinical Smart Nanotechnologies, Institute for Regenerative Medicine, Sechenov University, 119991 Moscow, Russia.
  • Laboratory of Digital Microscopic Analysis, Institute for Regenerative Medicine, Sechenov University, 119991 Moscow, Russia.
  • Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
  • World-Class Research Center "Digital Biodesign and Personalized Healthcare", I. M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.

ORCID-Profile: Timofey O Klyucherev, Maria A Peshkova, Daria P Revokatova, Natalia B Serejnikova, Alexey L Fayzullin

Förderung

  • the Ministry of Science and Higher Education of the Russian Federation
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Klyucherev, T. O., Peshkova, M. A., Revokatova, D. P., Serejnikova, N. B., Fayzullina, N. M., Fayzullin, A. L., Ershov, B. P., Khristidis, Y. I., Vlasova, I. I., Kosheleva, N. V., Svistunov, A. A., & Timashev, P. S. (2024). The Therapeutic Potential of Exosomes vs. Matrix-Bound Nanovesicles from Human Umbilical Cord Mesenchymal Stromal Cells in Osteoarthritis Treatment. International Journal of Molecular Sciences, 25(21), 11564. https://doi.org/10.3390/ijms252111564

Vancouver

Klyucherev TO, Peshkova MA, Revokatova DP, Serejnikova NB, Fayzullina NM, Fayzullin AL, et al. The Therapeutic Potential of Exosomes vs. Matrix-Bound Nanovesicles from Human Umbilical Cord Mesenchymal Stromal Cells in Osteoarthritis Treatment. International Journal of Molecular Sciences. 2024;25(21):11564. doi:10.3390/ijms252111564

BibTeX
@article{Klyucherev2024,
  author = {Klyucherev, Timofey O and Peshkova, Maria A and Revokatova, Daria P and Serejnikova, Natalia B and Fayzullina, Nafisa M and Fayzullin, Alexey L and Ershov, Boris P and Khristidis, Yana I and Vlasova, Irina I and Kosheleva, Nastasia V and Svistunov, Andrey A and Timashev, Peter S},
  title = {The Therapeutic Potential of Exosomes vs. Matrix-Bound Nanovesicles from Human Umbilical Cord Mesenchymal Stromal Cells in Osteoarthritis Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {21},
  pages = {11564},
  doi = {10.3390/ijms252111564}
}
Kostenlos starten →